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Abstract
Bluetongue virus serotype 8 (BTV-8), which caused an epidemic in ruminants in central Western Europe in 2006
and 2007, seems to differ from other bluetongue serotypes in that it can spread transplacentally and has been
associated with an increased incidence of abortion and other reproductive problems. For these reasons, and also
because BTV-8 is threatening to spread to other parts of the world, there is a need for more information on the
consequences of infection during pregnancy. The aim of the present study was to investigate whether hatched (i.e.
zona pellucida-free) in vitro produced bovine blastocysts at 8-9 days post insemination are susceptible to BTV-8
and whether such infection induces cell death as indicated by apoptosis. Exposure of hatched in vitro produced
bovine blastocysts for 1 h to a medium containing 103.8 or 104.9 TCID50 of the virus resulted in active viral
replication in between 25 and 100% of the cells at 72 h post exposure. The infected blastocysts also showed
growth arrest as evidenced by lower total cell numbers and a significant level of cellular apoptosis. We conclude
from this in vitro study that some of the reproductive problems that are reported when cattle herds are infected
with BTV-8 may be attributed to direct infection of blastocysts and other early-stage embryos in utero.
Introduction
Bluetongue virus (BTV) is an orbivirus belonging to the
Reoviridae family. It has 24 known serotypes and
recently a likely 25th serotype has been identified
amongst goats in Switzerland [1,2]. Prior to 2006 BTV
was known to occur throughout much of the world
between latitudes of approximately 40° north and 35°
south [3], but a more northerly incursion of BTV sero-
type 8 (BTV-8) in central-Western European countries
was detected which commenced in August 2006. In
Belgium, for example, epidemiological studies at the end
of 2006 revealed an overall herd and true within-herd
prevalence in ruminants of 83.3% and 23.8%, respec-
tively [4]. The economic impact was devastating, with
morbidity, mortality, reproductive failure including abor-
tions, transport and export restrictions and other
control measures [1,5]. The exact cost of these recent
BTV infections has not been calculated, but in 1996,
prior to the European outbreaks, worldwide losses due
to BTV infections in livestock were estimated to be US$
3 billion per year [6].
In contrast to infections with other BTV serotypes in
other parts of the world, many BTV-8 infected cattle and
sheep show clear clinical signs and/or pathological lesions,
including fever, crusts/lesions of the nasal and oral
mucosa, salivation, conjunctivitis, coronitis, muscle necro-
sis, and stiffness of the limbs [7]. More importantly, BTV-
8 seems to differ from other BTV serotypes in that it
spreads transplacentally and thereby may lead to an
increased incidence of abortion [8,9]. In the past, transpla-
cental infections with BTV were always thought to have
been caused by modified live vaccine strains of the virus
[10]. The pathological mechanisms whereby embryos and
foetuses are harmed by wild type BTV-8, and the conse-
quences with regards to impaired fertility and/or congeni-
tal problems in calves infected in utero remain unknown.
Bowen et al. [11] showed that zona pellucida-free bovine
and murine morulae are susceptible to infection with
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BTV-11 and BTV-17 in vitro, with virus replication and
cytopathic effects on the embryos. However, studies with
BTV-1, -10, -11, -13 and -17 have also shown that zona
pellucida-intact bovine embryos could not be infected in
vitro [12-14]. Based on these and other studies it was con-
cluded that the risk of transmitting BTV infection during
bovine embryo transfer is negligible when the guidelines
of the International Embryo Transfer Society (IETS) are
followed [15].
The apparently unique ability of BTV-8 amongst BTV
serotypes to cross the placenta and to produce prenatal
infection indicates that the original research on BTV
interaction with bovine embryos should be reappraised
[16]. Also, since BTV-8 is threatening to spread more
widely over the globe [1], there is an urgent need for
more information on the consequences of infection dur-
ing pregnancy. In vivo derived embryos lose their zonae
pellucidae shortly after blastocyst formation and conse-
quently they are likely to be exposed to BTV-8 virus in
the uterus during viremia. The aim of the present study
was to investigate a) whether hatched (zona pellucida-
free) in vitro produced bovine blastocysts (at day 8-9
post insemination) are susceptible to BTV- 8 infection
and, if so whether such infection induces apoptosis.
Materials and methods
Media and reagents
Tissue culture medium-199 (TCM-199), Basal Medium
Eagle (BME) amino acids, Minimal Essential Medium
(MEM), non-essential amino acids, and gentamicin were
obtained from GIBCO-BRL Life Technologies (Merel-
beke, Belgium). For virus exposure Minimal Essential
Medium (MEM, 21430-020, GIBCO-BRL Life Technolo-
gies) was used. All other media components and
reagents were bought from Sigma (Bornem, Belgium).
Prior to their use, all the media were passed through a
sterile 0.22 μm filter (Millipore Corporation, New
Bedford, MA, USA).
In vitro production of blastocysts
Bovine blastocysts were produced by the in vitro meth-
ods used routinely in our laboratory [17]. Briefly, after
collecting bovine ovaries from an abattoir, the oocytes
were aspirated from follicles measuring between 4 and 8
mm in diameter and cultured for 20-24 h at 38.5°C in
5% CO2 in air in groups of 100 in 500 μL modified
bicarbonate buffered TCM-199 supplemented with 20%
heat-treated foetal calf serum (FCS) (Biochrom AG, Ber-
lin, Germany). Foetal calf serum is a valuable source
of growth factors and heat-treatment is used to inactivate
any potential microbial contaminants. Spermatozoa were
separated out from frozen-thawed bovine semen using
Percoll-gradient centrifugation (Pharmacia, Uppsala,
Sweden), and then washed. The matured oocytes were
incubated with a sperm (sp) concentration of 1 × 106 sp/
mL in an in vitro fertilisation medium consisting of bicar-
bonate buffered Tyrode albumin lactate pyruvate (TALP)
solution, supplemented with bovine serum albumin
(BSA, fraction V, A6003, Sigma-Aldrich, Bornem, Bel-
gium) (6 mg/mL) and heparin (25 μg/mL). After 20-24 h
of incubation the presumed zygotes were vortexed to
remove excess sperm and cumulus cells and subsequently
cultured for a further seven days (i.e. to the hatched blas-
tocyst stage) in 50 μL droplets of synthetic oviduct fluid
supplemented with amino acids and FCS (SOFaa + 5%
FCS) in an atmosphere of 5% CO2, 5% O2 and 90% N2
under mineral oil (Sigma-Aldrich).
Exposure of hatched blastocysts to BTV-8
We used BTV-8 Bel 2006, an isolate that was originally
obtained from an infected sheep by culture of blood on
embryonated hens’ eggs and then passaged 1 to 3 times
on Baby Hamster Kidney (BHK-21) cells [18]. Groups of
4 to 8 hatched blastocysts were exposed to the virus by
placing them in 800 μL of MEM containing 103.8
(experiment 1 and 2) or 104.9 (experiment 2) tissue cul-
ture infectious doses with 50% endpoint (TCID50) of
BTV-8 and incubating them for 1 h at 39°C in an atmo-
sphere of 5% CO2 in air. Mock-exposure of groups of 4
to 8 control blastocysts in 800 μL SOF or 800 μL MEM
(two groups) without virus was used to evaluate any
negative effects of MEM on blastocyst viability. After
1 h of exposure, all blastocysts in the group were
washed ten times by passing through 10 petri-dishes
each containing 5 mL of HEPES-buffered TALP, follow-
ing the guidelines of the IETS manual on embryo pro-
cessing [15]. The groups of blastocysts were then
cultured for a further 48, 60, 72 or 96 h at 39°C in an
atmosphere of 5% CO2, 5% O2 and 90% N2.
Experiment 1: Detection of BTV-8 antigen expression in
exposed blastocysts
The proportion of infected blastocysts after each period
of culture was determined by indirect immunofluores-
cence (IF). In order to validate the staining, a BTV-8
infected BHK-21 monolayer was examined in the same
way and used as a positive control. All samples were
washed three times in polyvinyl pyrrolidone (PVP) solu-
tion (1 mg/mL PVP in phosphate buffered saline) and
subsequently fixed in 4% paraformaldehyde at 4°C for
between 1 h and 12 h. After fixation, samples were
stored in a similar PVP solution at 4°C until staining.
Prior to staining blastocysts were permeabilised in a
detergent (0.5% Triton X-100 (Sigma-Aldrich) in PVP)
for 1 h, whereas the positive cell line was permeabilised
for just 2 min. In order to prevent aspecific binding of
the primary antibody to the samples, blocking was initi-
ally done in 10% FCS for 1 h at room temperature (RT).
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Samples were then washed in a similar PVP solution
and incubated overnight in a 1:100 dilution of BTV-8
monoclonal antibody (8A3B.6, ID-Vet, Montpellier,
France) at 4°C. Next, the samples were blocked again in
10% goat serum in PVP for 1 h at RT to prevent aspeci-
fic binding of the secondary antibody. Afterwards, sam-
ples were incubated for 1 hour in a 1:100 dilution of
FITC labelled goat-anti-mouse antibodies (Molecular
Probes, Invitrogen, Merelbeke, Belgium) and subse-
quently incubated with 0.5% propidium iodide (Molecu-
lar Probes, Invitrogen, Merelbeke, Belgium) for 30 min
at RT to stain the nuclei. After mounting the blasto-
cysts, and the positive control BHK-21 monolayer, in
glycerol with 1,4-diazabicyclo (2.2.2) octane (25 g/mL),
the number of blastocysts positive for the BTV-8 anti-
gen in one or more embryonic cells was evaluated by
means of a Leica DM/RBE fluorescence microscope at a
magnification of 400× (Leica, Aartselaar, Belgium).
Experiment 2: Combined detection of BTV-8 antigen
expression and apoptosis
The same procedures were followed as in Experiment 1
except that a Texas Red labelled goat-anti-mouse anti-
body was used as secondary antibody to detect viral
antigen expression, and Terminal deoxynucleotidyl
transferase (TdT) fluorescein-dUTP Nick End Labelling
(TUNEL, Roche Diagnostics, Mannheim, Germany) was
used to detect apoptosis. Nuclei were stained with
Hoechst 33342 (Molecular Probes, Invitrogen, Merel-
beke, Belgium) which selectively binds to double-
stranded DNA. Thus, after their incubation in the sec-
ondary antibody and two additional washes in PVP,
blastocysts were further incubated in the reagent for
TUNEL for 1 h at 37°C in the dark, and subsequently
washed again in PVP. Finally all of the blastocysts were
subjected to Hoechst 33342 staining. Mounting and eva-
luation were the same as in the first experiment. The
apoptotic cell ratio was defined as the percentage of
apoptotic cells/total cell number.
Staining controls
Negatively stained controls were provided by omitting
the first, second or both antibodies in the staining pro-
cedure and these showed no background staining
(resulting data not shown). The degrees of cell cycle
arrest and loss of cells in the infected BHK-21 mono-
layers were increased compared with those in a control,
non-infected BHK-21 monolayer. Both staining proto-
cols caused all remaining cells in the infected mono-
layers to stain positive for BTV-8 (data not shown).
Statistical analysis
Statistical analysis of the data from experiment 2 for
blastocysts examined 48 hours post exposure (hpe) and
for those at 72 hpe was done separately. Within each
treatment group mixed model univariate analysis of var-
iance was performed to evaluate the total cell number.
The apoptotic cell ratio in each treatment group in
experiment 2 was also analysed using logistic regression
analysis. Being apoptotic or not was included as the
dependent variable and treatment was the independent
variable.
Results
Experiment 1: Detection of viral antigen expression in
blastocysts exposed to BTV-8
All of the control, i.e. mock-exposed blastocysts (SOF
and MEM) were negative for the BTV-8 virus antigen at
all time points (Figure 1, rows A and B). At 48 hpe only
one out of 7 exposed blastocysts was positive for viral
antigen, but in this case the antigen was detected in all
embryonic cells (Figure 1, row C). At 60 hpe, all
exposed blastocysts (n = 6) were negative, whereas at
72 hpe and 96 hpe all exposed blastocysts had 25% to
100% BTV-8 positive cells (n = 6 at 72 hpe and n = 7 at
96 hpe) (Figure 1, row D). Furthermore one blastocyst
at 72 hpe and 2 blastocysts at 96 hpe showed morpholo-
gical signs of degeneration (Figure 1, rows E and F).
Experiment 2: Combined detection of viral antigen
expression and apoptosis
All BTV-8 exposed blastocysts showed at least some
BTV-8 positive blastomeres. At 48 hpe and 72 hpe,
respectively, 45% and 38% of the exposed blastocysts
were BTV-8 positive in all embryonic cells (Figure 2,
rows A and C). Approximately 25% of the blastocysts at
both of these time points post exposure showed clear
signs of degeneration (Figure 2, row B). The apoptotic
cell ratio in the virus exposed blastocysts was signifi-
cantly higher than in mock-exposed, control blastocysts
(Table 1), but when only a few cells were infected, or in
cases where there was degeneration, there was no clear
co-localisation between the TUNEL (FITC)-positive and
the BTV-8 (Texas Red labelled antibody) positive cells
(Figure 2, rows B and D). The total cell number was
substantially lower in blastocysts exposed to BTV-8 in
comparison with mock-exposed, control blastocysts,
although this difference was not found to be statistically
significant, probably because of the large within group
variation (Table 1). Mock-exposed, control blastocysts
(SOF and MEM) stained by exactly the same procedure
as BTV-8 exposed blastocysts were all negative for
BTV-8 (Figure 3).
Discussion
During the recent BTV-8 epidemic in central-Western
Europe, it was clearly shown that the virus was able to
spread transplacentally in between 10% and 33% of the
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affected pregnant cattle [8,19]. Early transplacental
infection with BTV-8 (between 30 and 70 days of gesta-
tion) is thought to result in embryonic death and
resorption or abortion, which might not be noticed.
Later, between days 70 and 130, before the foetus is
fully immunocompetent, the infection can affect the foe-
tal central nervous system leading to malformations,
such as hydranencephaly [9]. In these cases, the affected
calf usually dies within 2 months after birth. Problems
such as infertility and diminished health of the offspring
Figure 1 Blastocysts examined by immunofluorescence microscopy at different time points post exposure to BTV-8. Column 1:
propidium iodide (PI) staining of nuclei; Column 2: indirect fluorescein (FITC) labelled detection of BTV-8 antigen and Column 3: overlay of PI
and FITC staining. Row A: blastocyst negative for antigen at 48 h post exposure (hpe). Row B: blastocyst negative for antigen at 60 hpe. Row C:
blastocyst positive for antigen at 48 hpe. Row D: blastocyst completely positive for antigen at 72 hpe. Row E: blastocyst positive for antigen at
72 hpe. Row F: blastocyst positive for antigen at 96 hpe.
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have also been demonstrated when infections of the
dam occurred after 70 days of gestation [10]. After
130 days, the foetus becomes immunocompent and
should be able to clear a BTV-8 infection by production
of its own antibodies although the time of complete
clearance of the virus or viral RNA will depend on
when the intra-uterine infection occurred [8,20].
In the present study, we were able to confirm that
infection of hatched blastocysts at the very beginning of
gestation can be detrimental to their development. Pre-
vious studies with other serotypes of bluetongue virus
have shown that the virus can be found in uterine flush-
ings during viraemia, which indicates that embryos are
likely to be exposed to the virus, especially after hatching
[11]. Our in vitro studies have also shown that after
hatching of the blastocyst (around day 8 or 9 after fertili-
sation) the embryo blastomeres are susceptible to BTV-8
infection, which signifies that the virus can attach to and
penetrate through the cell membrane. Attachment and
penetration of cells by bluetongue virus is mediated by its
two outer capsid structural proteins, VP2 and VP5 [21].
Figure 2 Blastocysts examined for apoptosis at different time points post-exposure to BTV-8. Column 1: Hoechst staining of nuclei;
Column 2: terminal deoxynucleotidyl transferase (TdT) fluorescein-dUTP Nick End Labelling (TUNEL) for apoptosis detection and Column 3:
indirect immunofluorescent staining of viral BTV-8 antigen with a Texas-Red labelled secondary antibody. Column 4: overlays of the three
staining procedures. Row A: BTV-8 exposed blastocyst of excellent morphological quality at 48 hpe showing BTV-8 viral antigen in all its cells.
Row B: BTV-8 positive blastocyst at 48 hpe showing degeneration and a high proportion of apoptotic cells. Row C: BTV-8 positive blastocyst at
72 hpe with excellent morphological quality. Row D: BTV-8 positive blastocysts at 72 hpe which shows no colocalisation of apoptosis and BTV-8
infection, and which has an excellent morphology.
Table 1 Experiment 2: Cell numbers (mean ± SEM) and
apoptotic cell ratios (mean ± SEM) of blastocysts in








at 48 hpe at 48 hpe
SOF (n = 6) 213.3 ± 23.12 14.5 ± 0.98a
MEM (n = 5) 312.8 ± 100.97 7.0 ± 0.64b
BTV 103.8 (n = 7) 107.1 ± 21.47 18.9 ± 1.43c
BTV 104.9 (n = 4) 108.4 ± 18.72 11.8 ± 1.55a
at 72 hpe at 72 hpe
SOF (n = 5) 413.1 ± 119.61 3.9 ± 0.43a
MEM (n = 7) 331.7 ± 83.24 4.7 ± 0.44a
BTV 103.8 (n = 5) 129.3 ± 25.25 14.9 ± 1.29b
BTV 104.9 (n = 3) 105.7 ± 23.31 16.6 ± 2.6b
Mock-exposed, control blastocysts (SOF and MEM) were incubated in BTV-8
free SOF culture medium and MEM medium respectively. Virus exposed
blastocysts were exposed to two different titers of BTV-8 i.e. BTV 103.8 or BTV
104.9 TCID50 respectively.
abc Values with different superscript within the same time point and column
differ significantly.
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Very recently, cryo-electron microscopy has revealed the
structure of these capsid proteins [22]. The protein VP2,
which is also called the host attachment protein, has two
putative binding sites: an exposed receptor-binding tip
and an internal sialic acid-binding pocket. The virus initi-
ally binds to the membrane receptor of the host cell with
the tip of the VP2 protein, and this is followed by binding
via the sialic acid-pocket, which probably stabilises the
initial viral attachment [22]. The initial attachment via
the VP2 protein is followed by a clathrin-dependent
endocytosis and subsequent degradation of VP2 in the
endosome of the host cell [21]. VP5, the second outer
caspid protein of BTV, is responsible for viral penetration
through the cell membrane [22]. Although the exact nat-
ure of the receptor for the viral VP2 on the cell is
unknown, successful infection of our blastocysts with
BTV-8 indicates that these unknown (glyco)protein
receptors are present at the surface of the blastomeres of
hatched bovine blastocysts. Glycoprotein receptors play
important roles during fertilisation, embryo development
and embryo implantation [23-25]. Identification of the
nature of the VP2 receptor on the cell would allow more
detailed investigation of the interactions between BTV-8
and blastocysts and also viral interaction with zona pellu-
cid-intact (unhatched) embryos both in vivo and in vitro.
Once the virus has entered and replicated within the
cell, it then needs to leave the cell. In somatic cell cul-
tures the viral VP2 interacts with vimentin which
enables egress of virus particles from the cell [26]. The
expression of vimentin has been studied in different
types of bovine embryos and found to be significantly
reduced in cloned embryos, which suggests that these
are of lower quality than embryos produced by conven-
tional in vitro procedures [27]. Vimentin has, further-
more, been shown to play a crucial role in normal
posthatching development of bovine embryos [28], so it
can be assumed that its presence would have enabled
the BTV-8 virus to spread within and possibly between
the blastocysts in our experiments.
Apoptosis is known to play a central role in the
pathogenesis of bluetongue virus infection when the lat-
ter leads to tissue injury [29]. Our results showing that
BTV-8 infection of hatched blastocysts caused increased
apoptosis and developmental arrest suggest that this
could have an important role in the decreased fertility
that is sometimes observed during BTV-8 epidemics.
Mortola et al. have shown that when cells are treated
with purified VP2 and VP5 either alone or together,
both of these proteins are necessary to induce apoptosis
[29]. For reoviruses, however, it has been demonstrated
that in addition to the binding of outer viral capsid pro-
teins to the cell receptor, intracellular virus disassembly
is also necessary for apoptosis induction, but virus repli-
cation within the cell is not essential [30]. This might
explain why in some of our BTV-8 exposed blastocysts,
apoptosis and virus infection were not colocalised within
the blastomeres (Figure 2 row D column 4). When virus
spreads within the blastocyst and apoptosis leads to
embryonic arrest and death in vivo, the clinical outcome
will depend on the timing of embryonic death. Loss of
the embryos before day 14 will usually be followed by
regular return to oestrus at 21 days whereas embryonic
death after day 14 will often result in a delayed return
to oestrus.
Having shown in our present work that hatched
bovine blastocysts are susceptible to BTV-8 infection,
we believe that future research should investigate the
effect of insemination with BTV-8 infected semen and
also the effect of viremia of the dam during develop-
ment of early (i.e. zona pellucida-intact) embryos as well
as hatched blastocysts in vivo. Since the properties of
the zona pellucida are very different between in vitro
produced and in vivo derived embryos [16], additional
research is also needed to ascertain the susceptibility of
both types of zona pellucida-intact embryos to BTV-8
infection. Although it is unlikely that the virus would
penetrate through the zona pellucida, the possibility
cannot be excluded that virus particles may stick to the
zona and might not be removed by the thorough wash-
ing procedures advocated by the IETS [15,16].
In conclusion, we have shown that hatched bovine
blastocysts are susceptible to infection with BTV-8 and
that infection with this BTV serotype results in their
retarded development. Total numbers of cells in BTV-8
infected blastocysts were lower than in mock-exposed,
control blastocysts, and there was significantly more
Figure 3 Mock-exposed, non-infected hatched blastocyst. A: staining of the nuclei with Hoechst stain; B: apoptosis detection by TUNEL; C:
use of Texas Red labelled secondary antibody to show the absence of BTV-8 antigen; and D: a combination of the three procedures.
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apoptosis. Consequently, we believe that the reported
problems with herd fertility during a BTV-8 epidemic
may not be exclusively caused by BTV-8 induced mater-
nal effects in the cows (such as fever), but potentially
may also be attributed to direct infection of early
embryos in utero.
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